Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes
暂无分享,去创建一个
[1] S. Ghose. Glycemic Targets , 2018, TAJ: Journal of Teachers Association.
[2] K. Close,et al. American Diabetes Association 77th Scientific Sessions , 2017, Journal of diabetes.
[3] T. Skrivarhaug,et al. Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15–29 Years in Norway , 2016, Diabetes Care.
[4] J. Shaw,et al. Age-Specific Trends From 2000–2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People , 2016, Diabetes Care.
[5] P. Clarke,et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden , 2016, Diabetologia.
[6] G. King,et al. PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. , 2016, The Journal of clinical investigation.
[7] S. Wild,et al. Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals , 2016, Diabetologia.
[8] T. Byers. Excess Mortality among Persons with Type 2 Diabetes. , 2016, The New England journal of medicine.
[9] D. Giugliano,et al. Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study , 2016, Endocrine.
[10] J. Shaw,et al. Life expectancy of type 1 diabetic patients during 1997–2010: a national Australian registry-based cohort study , 2016, Diabetologia.
[11] A. Rosengren,et al. Excess Mortality among Persons with Type 2 Diabetes. , 2015, The New England journal of medicine.
[12] Jennifer K. Sun,et al. Cardiovascular Disease Protection in Long-Duration Type 1 Diabetes and Sex Differences , 2015, Diabetes Care.
[13] B. Zinman,et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. , 2015, JAMA.
[14] Jennifer K. Sun,et al. Characterization of Circulating and Endothelial Progenitor Cells in Patients With Extreme-Duration Type 1 Diabetes , 2014, Diabetes Care.
[15] J. Coresh,et al. Lifetime incidence of CKD stages 3-5 in the United States. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] Thomas J. Songer,et al. Improvements in the Life Expectancy of Type 1 Diabetes , 2012, Diabetes.
[17] S. Wild,et al. Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study , 2012, PLoS medicine.
[18] Jennifer K. Sun,et al. Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration , 2011, Diabetes Care.
[19] S. Kelsey,et al. Cause-Specific Mortality Trends in a Large Population-Based Cohort With Long-Standing Childhood-Onset Type 1 Diabetes , 2010, Diabetes.
[20] R. G. Miller,et al. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.
[21] T. Travison,et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? , 2010, Journal of the American College of Cardiology.
[22] Ronald Klein,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. , 2008, Ophthalmology.
[23] Jennifer K. Sun,et al. Clinical Factors Associated With Resistance to Microvascular Complications in Diabetic Patients of Extreme Disease Duration , 2007, Diabetes Care.
[24] T. Skrivarhaug,et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway , 2006, Diabetologia.
[25] I. Thompson,et al. Erectile dysfunction and subsequent cardiovascular disease. , 2005, JAMA.
[26] Douglas W Mahoney,et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. , 2004, Journal of clinical epidemiology.
[27] G. Gill,et al. Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort) , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[28] E. Rimm,et al. Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study , 2003, Annals of Internal Medicine.
[29] A. J. Swerdlow,et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes , 2003, Diabetologia.
[30] N. Calonge,et al. Validation of self-reported chronic conditions and health services in a managed care population. , 2000, American journal of preventive medicine.
[31] M M Bergmann,et al. Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults. , 1998, American journal of epidemiology.
[32] The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial , 1995, Diabetes.
[33] Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. , 1995, The American journal of cardiology.
[34] M B Brown,et al. A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.
[35] H A Feldman,et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.
[36] B E Ainsworth,et al. Accuracy of the College Alumnus Physical Activity Questionnaire. , 1993, Journal of clinical epidemiology.
[37] L. Kuller,et al. Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications Study Cohort , 1993, Diabetes Care.
[38] R. Klein,et al. Cause-specific mortality in a population-based study of diabetes. , 1991, American journal of public health.
[39] Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.